Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin Lymphoma

Explore clinical trials studying Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

214 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin Lymphoma trial results

Completed

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

NCT00096161

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
Locations
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

NCT01527045

Conditions
Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Blood Protein Disorders, +57 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

The Second Multicenter Hemophilia Cohort Study

NCT00341705

Conditions
Acquired Immunodeficiency Syndrome, Adenocarcinoma, Blood Coagulation Disorders, +46 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • University of California, Davis Davis, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 48 locations
View Trial Details
Completed

Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

NCT00928018

Conditions
Graft vs Host Disease, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions